Gene · 7939
NIH grants1,570
NIH grants whose papers are about the gene, through NIH's grant-paper links.
821 to 840 of 1,570
Download this page as JSON| Grant | Title | LAP papers | Newest fiscal year |
|---|---|---|---|
| P30GM110758 | Molecular Design of Advanced Biomaterials | 8 | 2018 |
| R21HD090662 | Rapid 3D-printing of Multi-functional Adaptive Nerve Conduits | 4 | 2018 |
| R01EY024564 | Oral therapy for diabetic retinopathy using ACE2/Ang1-7 bioencapsulated in plant cells | 3 | 2018 |
| K08DK102978 | Epicutaneous Tolerance Induction for the Treatment of Colitis | 2 | 2018 |
| P50CA121973 | SPORE in Skin Cancer | 2 | 2018 |
| R01AR057837 | Microengineered Osteons for Bone Tissue Engineering | 2 | 2018 |
| R01EB019430 | Cholesterol Sensitivity and Mechanisms of MSC Responses to 3D Substrate Rigidity | 2 | 2018 |
| R01GM075249 | Roles of Chromosomal Factors in Chromosome Segregation | 2 | 2018 |
| R01GM082989 | Centromere Identity and Function | 2 | 2018 |
| R21AI131912 | Unbiased identification of HIV-derived antigens during latency and reactivation | 2 | 2018 |
| R21HD090680 | Elastic printable biomaterials for 3-D bioprinting of vascular conduit | 2 | 2018 |
| UG3TR002136 | Tissue Chip Modeling of Synovial Joint Pathologies: Effects of Inflammation and Adipose-Mediated Diabetic Complications | 2 | 2018 |
| F30DK105788 | Type 1 IFN in Type 1 Diabetes: Influencing Beta-Cell and CD8+ T cell interactions | 1 | 2018 |
| F31DE025788 | Injectable Macroporous Matrices to Enhance Stem Cell Survival and Craniofacial Repair | 1 | 2018 |
| F31HL134295 | Endothelial cell stability after pericyte loss through the Ang-1/Tie2 pathway | 1 | 2018 |
| G12MD007595 | Xavier RCMI Center for Cancer Research | 1 | 2018 |
| K22CA207458 | Genome Stability Regulation by the Nuclear Pore-Chromosome Axis and Defects in Tumor Cells | 1 | 2018 |
| K23DK105229 | Therapeutic Monitoring and Targeting of Neutrophil Activation in Pediatric IBD | 1 | 2018 |
| K25HL122305 | Observational data and treatment effectiveness: which methods work best? | 1 | 2018 |
| K99CA218871 | Cell Division Errors as a Mechanism Driving Massive Genomic Rearrangements | 1 | 2018 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7939/grants?page=42